The Valley Desk

NCT05422911 · Interventional trial

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Overall registry status Recruiting

Phase 2

Conditions Castrate-sensitive, Castrate-sensitive Prostate Cancer, Metastatic Cancer, Neoplasm, Prostate

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov